Several studies have shown that CD54 is highly expressed in CD34+ cells and CD8+ lymphocytes in MDS patients, and the soluble CD54 level in plasma of MDS is also significantly increased, which is an important indicator of cytopenia, dysplasia, and disease progression to AML (10–14). Here, CD34 is linked to acute myeloid leukemia.